Clinical Trial Update: Contrast Enhanced Ultrasound in COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating contrast-enhanced ultrasound in pediatric COVID-19 with results posted in March 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multisystem Inflammatory Syndrome in Children

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Covid19, Multisystem Inflammatory Syndrome in Children (MIS-C) | Phase 3 | Status: COMPLETED | Results posted: 2024-03-08